Kymera Therapeutics, Inc. (KYMR) SEC Filings — 2025
15 SEC filings for Kymera Therapeutics, Inc. (KYMR) in 2025.
Filings
- Kymera Therapeutics, Inc. 8-K Filing — 8-K · Dec 10, 2025
- Kymera Therapeutics Files 8-K — 8-K · Dec 8, 2025
- Kymera's R&D Surge Drives 46% Wider Loss, Cash Reserves Tighten — 10-Q · Nov 4, 2025
- Kymera Therapeutics Files 8-K on Officer/Director Changes — 8-K · Sep 3, 2025
- Kymera's Q2 Loss Widens Amid R&D Surge, Collaboration Revenue Dip — 10-Q · Aug 11, 2025
- Kymera Therapeutics Reports Shareholder Vote Matters — 8-K · Jun 27, 2025
- Kymera Therapeutics Files 8-K — 8-K · Jun 25, 2025
- Kymera Therapeutics Files 8-K — 8-K · Jun 2, 2025
- Kymera Therapeutics Files 8-K — 8-K · May 9, 2025
- Kymera Therapeutics Files Q1 2025 10-Q — 10-Q · May 9, 2025
- Kymera Therapeutics DEF 14A: Executive Compensation Details — DEF 14A · Apr 29, 2025
- Kymera Therapeutics Announces Executive and Board Changes — 8-K · Mar 3, 2025
- Kymera Therapeutics Files 8-K — 8-K · Feb 27, 2025
- Kymera Therapeutics, Inc. 10-K Filing — 10-K · Feb 27, 2025
- Kymera Therapeutics Files 8-K — 8-K · Jan 14, 2025